The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation
dc.contributor.author | Hildebrandt, Gerhard C. | en_US |
dc.contributor.author | Choi, Sung W. | en_US |
dc.contributor.author | Mueller, Gunnar | en_US |
dc.contributor.author | Olkiewicz, Krystyna M. | en_US |
dc.contributor.author | Moore, Bethany B. | en_US |
dc.contributor.author | Cooke, Kenneth R. | en_US |
dc.date.accessioned | 2008-03-06T19:12:36Z | |
dc.date.available | 2009-04-09T15:01:13Z | en_US |
dc.date.issued | 2008-04 | en_US |
dc.identifier.citation | Hildebrandt, Gerhard C.; Choi, Sung W.; Mueller, Gunnar; Olkiewicz, Krystyna M.; Moore, Bethany B.; Cooke, Kenneth R. (2008). "The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation." Pediatric Blood & Cancer 50(4): 911-914. <http://hdl.handle.net/2027.42/58037> | en_US |
dc.identifier.issn | 1545-5009 | en_US |
dc.identifier.issn | 1545-5017 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/58037 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17455319&dopt=citation | |
dc.description.abstract | Acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (allo-BMT) predominantly involves a Th1-type cytokine response. Interestingly, the Th2-cytokine, Interleukin-13 (IL-13), produced by alloreactive donor T cells in vitro was recently shown to correlate with clinical aGVHD severity. Using an established mouse model, we show that the systemic cytokine milieu following allo-BMT with IL-13−/− donors is characterized by decreases in serum Th2 cytokines and an increase in serum TNFΑ, and ultimately correlates with higher aGVHD mortality compared to allogeneic controls. In vitro studies further demonstrate that both exogenous and T cell-derived IL-13 can regulate TNFΑ production by macrophages following lipopolysaccharide stimulation. Thus, donor-derived IL-13 may have a role in modulating inflammatory cytokine release that is associated with aGVHD. Pediatr Blood Cancer 2008;50:911–914. © 2007 Wiley-Liss, Inc. | en_US |
dc.format.extent | 139616 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Hematology and Oncology, University of Regensburg Medical School, D-93053 Regensburg, Germany ; Department of Pediatrics, Division of Hematology and Oncology, Bone Marrow Transplantation Program, University of Michigan, Ann Arbor, 48109, Michigan ; Department of Hematology and Oncology, University of Regensburg Medical School, Franz-Josef-Strauß Allee 11, D-93053 Regensburg, Germany. | en_US |
dc.contributor.affiliationum | Department of Pediatrics, Division of Hematology and Oncology, Bone Marrow Transplantation Program, University of Michigan, Ann Arbor, 48109, Michigan | en_US |
dc.contributor.affiliationum | Department of Pediatrics, Division of Hematology and Oncology, Bone Marrow Transplantation Program, University of Michigan, Ann Arbor, 48109, Michigan | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, 48109, Michigan | en_US |
dc.contributor.affiliationum | Department of Pediatrics, Division of Hematology and Oncology, Bone Marrow Transplantation Program, University of Michigan, Ann Arbor, 48109, Michigan | en_US |
dc.contributor.affiliationother | Department of Hematology and Oncology, University of Regensburg Medical School, D-93053 Regensburg, Germany | en_US |
dc.identifier.pmid | 17455319 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/58037/1/21228_ftp.pdf | |
dc.identifier.doi | http://dx.doi.org/10.1002/pbc.21228 | en_US |
dc.identifier.source | Pediatric Blood & Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.